These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1639 related items for PubMed ID: 9834044
41. The role of the new beta-blockers in treating cardiovascular disease. Weber MA. Am J Hypertens; 2005 Dec; 18(12 Pt 2):169S-176S. PubMed ID: 16373195 [Abstract] [Full Text] [Related]
43. In vivo beta3-adrenergic stimulation of human thermogenesis and lipid use. Schiffelers SL, Blaak EE, Saris WH, van Baak MA. Clin Pharmacol Ther; 2000 May; 67(5):558-66. PubMed ID: 10824635 [Abstract] [Full Text] [Related]
44. Stereoselective increase of plasma concentrations of the enantiomers of propranolol and atenolol during exercise. Stoschitzky K, Kahr S, Donnerer J, Schumacher M, Luha O, Maier R, Klein W, Lindner W. Clin Pharmacol Ther; 1995 May; 57(5):543-51. PubMed ID: 7768077 [Abstract] [Full Text] [Related]
45. Left ventricular dynamics and plasma catecholamines during isometric exercise in patients following cardiac transplantation. Roca J, Caturla MC, Hjemdahl P, Masotti M, Augé JM, Oriol A, Crexells C. Eur Heart J; 1991 Aug; 12(8):928-36. PubMed ID: 1915431 [Abstract] [Full Text] [Related]
46. Cardioprotection, attenuated systemic inflammation, and survival benefit of beta1-adrenoceptor blockade in severe sepsis in rats. Ackland GL, Yao ST, Rudiger A, Dyson A, Stidwill R, Poputnikov D, Singer M, Gourine AV. Crit Care Med; 2010 Feb; 38(2):388-94. PubMed ID: 19829100 [Abstract] [Full Text] [Related]
47. Effects of an inhaled β2-agonist on cardiovascular function and sympathetic activity in healthy subjects. Snyder EM, Wong EC, Foxx-Lupo WT, Wheatley CM, Cassuto NA, Patanwala AE. Pharmacotherapy; 2011 Aug; 31(8):748-56. PubMed ID: 21923601 [Abstract] [Full Text] [Related]
48. Cardiovascular effects of short-term selective alpha 1-adrenergic blockade with terazosin in patients with essential hypertension. Beretta-Piccoli C, Ferrier C, Weidmann P. J Hypertens Suppl; 1985 Dec; 3(3):S231-4. PubMed ID: 2908818 [Abstract] [Full Text] [Related]
49. Comparative effects of atenolol and cicloprolol on cardiac performance in coronary heart disease. Silke B, Verma SP, Sharma SK, Frais MA, Reynolds G, Taylor SH. J Cardiovasc Pharmacol; 1989 Jan; 13(1):155-61. PubMed ID: 2468927 [Abstract] [Full Text] [Related]
51. Effects of 6-hydroxydopamine on hemodynamic function in the pithed rat. Vollmer RR, Fluharty SJ. J Pharmacol Exp Ther; 1987 Feb; 240(2):421-7. PubMed ID: 3100776 [Abstract] [Full Text] [Related]
52. Low-dose enoximone therapy in pre-transplant patients: hemodynamic, echocardiographic, and neurohumoral findings. Park JW, Heinzler R, Wirtz JH, Fieten-Rumswinkel M, Braun P, May E, Hetzer R, Heinrich KW. Z Kardiol; 1994 Feb; 83 Suppl 2():49-53. PubMed ID: 8091824 [Abstract] [Full Text] [Related]
53. Efficacy of landiolol in attenuating hemodynamic responses to local epinephrine infiltration in patients undergoing vaginal total hysterectomy. Hirota K, Baba S, Fukushi S, Muraoka M, Matsuki A. J Anesth; 2005 Feb; 19(1):17-20. PubMed ID: 15674510 [Abstract] [Full Text] [Related]
54. Adding beta-2 agonism does not improve beta-1 blockade exercise responses in hypertensives. Rueckert PA, Slane PR, Hanson P. Med Sci Sports Exerc; 1994 Aug; 26(8):945-50. PubMed ID: 7968427 [Abstract] [Full Text] [Related]
55. [The effects of bisoprolol and atenolol on glucose metabolism in hypertensive patients with non-insulin-dependent diabetes mellitus]. Vulpis V, Antonacci A, Prandi P, Bokor D, Pirrelli A. Minerva Med; 1991 Apr; 82(4):189-93. PubMed ID: 1673233 [Abstract] [Full Text] [Related]
56. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension. Man in't Veld AJ, Schalekamp MA. Postgrad Med J; 1983 Apr; 59 Suppl 3(689):140-58. PubMed ID: 6139800 [Abstract] [Full Text] [Related]
57. Exercise tolerance after beta blockade in recent cardiac transplant recipients. Buendía Fuentes F, Almenar Bonet L, Martínez-Dolz L, Sancho-Tello de Carranza MJ, Moro López J, Agüero Ramón-Llin J, Sánchez-Lázaro I, Sánchez-Gómez JM, Raso Raso R, Navarro Manchón J, Salvador Sanz A. Transplant Proc; 2009 Apr; 41(6):2250-2. PubMed ID: 19715889 [Abstract] [Full Text] [Related]
58. [Left ventricular function in hypertension. Echographic evaluation before and after beta blockade (atenolol)]. Dany F, Lagrée S, Clémenty J, Prague Y, Salamon R, Dallocchio M. Arch Mal Coeur Vaiss; 1979 Jun; 72(6):662-8. PubMed ID: 40535 [No Abstract] [Full Text] [Related]
59. Long-term hypotensive treatment with nitrendipine in mild to moderate essential hypertension: preliminary results of a placebo-controlled study versus atenolol. Palombo C, Marabotti C, Genovesi-Ebert A, Giuliano G, Giaconi S, Fommei E, Mezzasalma L, Ghione S. J Cardiovasc Pharmacol; 1987 Jun; 10 Suppl 10():S90-5. PubMed ID: 2455153 [Abstract] [Full Text] [Related]
60. Modest antihypertensive effect of epanolol, a beta 1-selective receptor blocker with beta 1 agonist activity: an acute and long-term hemodynamic study at rest and during exercise and double crossover comparison with atenolol on ambulatory blood pressure. Omvik P, Lund-Johansen P, Haugland H. Cardiovasc Drugs Ther; 1993 Feb; 7(1):125-32. PubMed ID: 8097925 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]